Three clinical trials have examined the efficacy and safety of single dose azithromycin (30 mg/kg) in children with uncomplicated acute otitis media (AOM). In the first trial, a small pilot study ...

While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults.